Dr. Howard Smith Reports

Topical Pain Killers Are Toxic


Listen Later


Vidcast: 

https://www.instagram.com/p/C5Wu4hYLn2O/


The FDA is now out with a warning about skin creams sold for use after tattooing, piercings, laser hair removal, and dermabrasion.  Most of these agents contain the local anesthetic lidocaine in concentrations that are dangerous. The FDA warns that using agents with lidocaine concentrations above 4% is dangerous.


The agency has fired off cease and desist warning letters to 6 companies.


The companies and their dangerous products include:

  • TKTX Company: TKTX Numb Maximum Strength Pain Reliever, Mithra+ 10% Lidocaine, TKTX During Procedure Numbing Gel 40% and J-CAIN cream [LIDOCAINE] 29.9%
  • SeeNext Venture, Ltd.: NumbSkin 5% Lidocaine Numbing Cream (15 grams), NumbSkin 5% Lidocaine Numbing Cream (30 grams) and NumbSkin 10.56% Lidocaine Numbing Cream
  • Tattoo Numbing Cream Co.: Signature Tattoo Numbing Cream and Miracle Numb Spray
  • Sky Bank Media, LLC, doing business as Painless Tattoo Co.: Painless Tattoo Numbing Cream and Painless Tattoo Numbing Spray
  • Dermal Source, Inc.: New & Improved Blue Gel, Superior Super Juice, Premium Pro Plus, Five-Star Vasocaine and Maximum Zone 1
  • Indelicare, doing business as INKEEZE: Ink Eeze Original B Numb Numbing Gel, Ink Eeze B Numb Numbing Spray Black Label and Ink Eeze B Numb Numbing Foam Soap

  • In general, avoid lidocaine products more concentrated than 4%, don’t use them on injured skin, and don’t wrap the skin with plastic coverings after applying the medications.  High concentrations of lidocaine in the bloodstream causes arrhythmias, seizures, and respiratory problems.


    https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-avoid-certain-topical-pain-relief-products-due-potential-dangerous-health


    #topical #analgesics #lidocaine #tattoo #piercing #dermabrasion #hairremoval


    ...more
    View all episodesView all episodes
    Download on the App Store

    Dr. Howard Smith ReportsBy Howard G. Smith MD, AM